PROMASTER - PROspective Cohort MRC ABPI STratification and Extreme Response Mechanism in Diabetes

NCT02105792 · clinicaltrials.gov ↗

COMPLETED

Status

820

Enrollment

OTHER

Sponsor class

Conditions

Diabetes

Interventions

DRUG: second- or third-line glucose-lowering diabetes treatment

Sponsor

Royal Devon and Exeter NHS Foundation Trust

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]